CD44 and breast carcinoma: In basal/HER2+ breast cancer cell lines, Menendez and colleagues showed that EMT-associated transcription factors (Snail2 and Slug) enhance resistance to trastuzumab via inducing a BCSC phenotype (CD44+CD24−/low) (Oliveras-Ferraros et al., 2012).